Pedro Pimentel-Coelho

@ppimentel-coelho.bsky.social

Neuroscientist at the Federal University of Rio de Janeiro 🇧🇷 Interested in neuroimmunology, glial cells, and neurological disorders.

Thrilled to share: we show that neuronal hyperactivity drives C1q-mediated synapse loss via brain-recruited B cell/IgM, revealing unexpected neuroimmune crosstalk in the adult brain. Congrats to Gerard Crowley who led this w/ resilience & creativity & our whole team! www.science.org/doi/10.1126/...

C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain

Complement component 1q (C1q), the initiator of the classical complement cascade, mediates synaptic elimination in development and disease, yet the triggers for its deposition on synapses remain uncle...

science.org

This news article is very informative and reinforces an important point: so far, there is no clinical evidence supporting umbilical cord-derived cell therapies for autism. More broadly: there is still no clinical evidence supporting their use for any neurological condition, in adults or children.

‘Autistic kids are being experimented on’: inside America’s booming market for unproven stem cell infusions

Feeling abandoned and overwhelmed, families are turning to controversial new therapies backed by the US health secretary

theguardian.com

Our latest paper is out in the European Journal of Pain! 🎉 We show that oromucosal treatment with a cannabidiol-enriched extract modestly reduces thermal hyperalgesia in rats with chronic neuropathic pain, without affecting infiltrating immune cells or microglial cell counts in the spinal cord.

Oromucosal Administration of a Cannabidiol‐Enriched Cannabis sp. Extract for 2 Weeks Moderately Reduces Cold Hyperalgesia in Rats With Neuropathic Pain

Background Chronic neuropathic pain (CNP) involves complex interactions between resident and peripheral immune cells, as well as modulation of the endocannabinoid system. Cannabis-based products hav...

onlinelibrary.wiley.com

'We primarily do comparative analysis using human stem cells/organoids and genetically modified mouse models, with some minor use of frog models. We use this approach because, for developmental anomalies, it is impossible to assess true function without in vivo models' @karenjliu.bsky.social

Why in vivo models of disease remain indispensable

Summary: The call to arms for alternatives to model organisms of disease will fail without ongoing integration with – and validation against – complex animal models and support from the animal modelli...

journals.biologists.com

Check out our latest preprint @biorxiv-neursci.bsky.social, led by the amazing Jayden O'Brien: T-cell distribution in the dorsal root ganglion across species, sex, and age: www.biorxiv.org/content/10.6... @jaydenobrien.bsky.social

T-cell distribution in the dorsal root ganglion across species, sex, and age

T-cells infiltrate somatosensory ganglia in response to nerve damage, autoimmune disease, and infection, contributing to sensory abnormalities and pain. In naive states, T-cells are rare in the rodent dorsal root ganglion (DRG) but have been reported in human and non-human primates without known relevant exposures. It remains unclear whether there are inherent evolutionary or species differences in DRG T-cell residence. Using a comparative biology approach, we investigated the frequency and distribution of T-cells in the mammalian DRG across humans, non-human primates, pigs, and rodents, and in humans investigated the contributions of sex and age. Spatial transcriptomics and immunofluorescence independently verified the robust presence of DRG T-cells at similar levels in humans, non-human primates, and pigs, but were fewer in rats and largely absent in mice. In humans, premenopausal females were more likely to have elevated DRG endoneurial T-cells than post-menopausal females or adult males. T-cells were detected in human dorsal root ganglion at as early as two months of age but were less abundant within the perineuronal niche. Most human DRG T-cells expressed distinct markers consistent with a resident memory (Trm) phenotype. We discuss the importance of studying the functional roles of DRG-resident T-cells and raise broader considerations for modelling peripheral nervous system disease. ### Competing Interest Statement TJP is co-founder of 4E Therapeutics, PARMedics, NuvoNuro, Nerveli, and Ted and Gregs. National Institutes of Health, https://ror.org/01cwqze88, U19NS130608

biorxiv.org

🚨 Our search for a postdoctoral researcher is still on! Contact me if you feel passionate about investigating neuroimmune mechanisms in neurodegenerative disorders. Candidates should have proven experience with rodent models of neurodegenerative disorders.

Sandro Da Mesquita@da-mesquita.bsky.social · 6mo ago

The Da Mesquita lab at Mayo Clinic (www.mayo.edu/research/lab...) is looking for a postdoctoral researcher to work on projects investigating the role(s) of the meningeal lymphatic vasculature in models of neurodegenerative diseases. Please spread the word and contact me in case you are interested! 😃